Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection

Springer Seminars in Immunopathology

Volumn 19, Issue 1, 1997, Pages 69-83

  Koziel, Margaret J ^a   Walker, Bruce D ^b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; CHRONIC HEPATITIS; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; LIVER; LIVER CELL DAMAGE; PRIORITY JOURNAL; REVIEW; VIRUS IMMUNITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENIC VARIATION; CELL SEPARATION; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HEPATITIS, CHRONIC; HUMANS; IMMUNITY, CELLULAR; IMMUNODOMINANT EPITOPES; LIVER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030827681     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00945026     Document Type: Review

References (90)

1. Aebischer T, Moskophidis D, Rohrer UH, Zinkernagel RM, Hengartner H (1991) In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc Natl Acad Sci USA 88:11 047
2. Alexander-Miller MA, Leggatt GR, Berzofsky JA (1996) Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 93:4102
3. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang SN, Chisari FV (1993) Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 178:1541
4. Baggiolini M, Dewald B, Maser B (1994) Interleukin-8 and related chemotactic cytokines - CXC and CC. Adv Immunol 55:97
5. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Alberti A, Bianchi FB (1995) Hepatitis C virus (HCV) genotype, tissue HCV antigens, heptacellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 95:2067
6. Battegay M, Fikes J, Di Bisceglie AM, et al (1995) Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 69:2462
7. Bergmann CC, Yao Q, Ho C-K, Buckwold SL (1996) Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J Immunol 157:3242
8. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De-Carli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells (See comments). Nature 369:407
9. Brander C, Walker BD (1995) The HLA-class I restricted CTL response in HIV-1 infection: identification of optimal epitopes. In: Korber BTM, Brandner D, Walker BD (eds) Theoretical biology and biophysics, 1995. HIV molecular immunology database. Los Alamos, ppIV-1 to IV-9
10. Bukh J, Miller RH, Purdell RH (1995) Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 15:41
11. Cerny A, Ferrari C, Chisari FV (1994) The class I-restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses (Review). Curr Top Microbiol Immunol 189:169
12. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV (1995) Cytotoxic T lymphocytes response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 95:521
13. Chen ZW, Shen L, Miller MD, Ghim SH, Hughes AL, Letvin NL (1992) Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J Immunol 149:4060
14. Chisari FV, Ferrari C (1995) Hepatitis B virus immunopathogenesis. Ann Rev Immunol 13:29
15. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 88:359
16. Choo QL, Richman KH, Han JH, et al (1991) Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451
17. De Campos-Iima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci M (1994) T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp Med 179:1297
18. Del Guercio MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A (1995) Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 154:685
19. Del Val M, Schlicht H-J, Ruppert T, Reddehase MJ, Koszinowski U (1991) Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighbouring residues in the protein. Cell 66:1145
20. Di-Bisceglie AM, Hoofnagle JH, Krawczynski K (1993) Changes in hepatitis C virus antigen in liver with antiviral therapy. Gastroenterology 105:858
21. Eisen HK, Sykulev Y, Tsomides TJ (1996) Antigen-specific T cell receptors and their reactions with complexes formed by peptides with major histocompatibility proteins. Adv Protein Biochem 149:1
22. Engelhard VH (1994) Structure of peptides associated with class I and class II MHC molecules. Ann Rev Immunol 12:181
23. Erickson AL, Houghton M, Choo Q-L, Weiner AJ, Ralston R, Muchmore E, Walker C (1993) Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 151:4189
24. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290
25. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 91:7792
26. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG (1994) Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 107:196
27. Gotch F, McMichael A, Smith G, Moss B (1986) Identification of viral molecules recognized by influenza-specific human cytotoxic t lymphocytes. J Exp Med 165:408
28. Grakoui A, Wychowski C, Lin C, Feinstone S, Rice C (1993) Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385
29. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV (1994) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 91:3764
30. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Sschreiber R, Chisari FV (1996) Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25
31. Harrer T, Harrer E, Kalams SA, Trocha A, Johnson RP, Elbeik T, Feinberg M, Cao H, Ho DD, Buchbinder S, Walker B (1996) Strong cytotoxic T cells and weak neutralizing antibodies in a subset of persons with long-term non-progressing HIV-1 infection. AIDS Res Human Retrovirus 12:585
32. Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, Ohnisi S, Aikawa T, Tanaka N, Yazaki Y, Mitamura K, Imawari M (1997) Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 25:705
33. Hoofnagle JH, Di Bisceglie AM (1997) The treatment of chronic viral hepatitis. N Engl J Med 336:347
34. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L (1991) Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381
35. Huczko EL, Bodnar WM, Benjamin D, Sakaguchi K, Zhu NZ, Shabanowitz J, Henderson RA, Appella E, Hunt DF, Engelhard VH (1993) Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 151:2572
36. Hudson BW, Wolff K, DeMartini JC (1979) Delayed-type hypersensitivity responses in mice infected with St. Louis encephalitis virus: kinetics of the response and effects of immunoregulatory agents. Infect Immun 24:71
37. Imawari M, Nomura M, Kaieda T (1989) Establishment of a human T cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A,non-B virus. Proc Natl Acad Sci USA 86:2883
38. Jassoy C, Johnson RP, Navia BA, Worth J, Walker BD (1992) Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J Immunol 149:3113
39. Johnson RP, Trocha A, Yang L, Mazzara GP, Panicali DL, Buchanan TM, Walker BD (1991) HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J Immunol 147:1512
40. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Murase K, Kusakabe A, Kurokawa S (1990) Comparisons of peripheral blood and hepatic lymphocyte subpopulations and interferon production in chronic viral hepatitis. J Clin Lab Immunol 33:1
41. Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, DAquila RT, Kurnick JT, Walker BD (1994) Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus I envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med 179:1261
42. Kita H, Hiroishi K, Moriyama T, Okamoto H, Kaneko T, Ohnishi S, Yazaki Y, Imawari M (1995) A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein. J Gen Virol 76:3189
43. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M (1993) HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039
44. Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Koppe B, Rosenberg W, Boyd D, Edwards A, Giagrande P, Phillips RE, McMichael AJ (1994) Naturally occurring HIV-1 gag variants antagonise cytotoxic T cell activity. Nature 369:403
45. Koup RA (1994) Virus escape from CTL recognition. J Exp Med 180:779
46. Koup RA, Pikora CA, Luzuriaga K, Brettler DB, Day ES, Mazzara GP, Sullivan JL (1991) Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 174:1593
47. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339
48. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD (1993) Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67:7522
49. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, Houghton M, Walker BD (1995) HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 96:2311
50. Kurilla MG, Swaminathan S, Welsh RM, Kieff E, Brutkiewicz RR (1993) Effects of virally expressed interleukin-10 on vaccinia virus infection in mice. J Virol 67:7623
51. Liaw YF, Lee CS, Tsai SL, Liaw BW, Chen TC, Sheen IS, Chu CM (1995) T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 22:1368
52. Marrogi AJ, Cheles MK, Gerber MA (1995) Chronic hepatitis C: analysis of the host immune response by immunohistochemistry. Arch Pathol Lab Med 119:232
53. McMichael AJ, Walker BD (1994) Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 8 [Suppl 1]:S155
54. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma (See comments) Science 272:1167
55. Meyerhans A, Dadaglio G, Vartanian JP, Langlade DP, Frank R, Asjo B, Plata F, Wain-Hobson S (1991) In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur J Immunol 21:2637
56. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 178:17
57. Nakagawa H, Shimomura H, Hasui T, Tsuji H, Tsuji T (1994) Quantitative detection of hepatitis C virus genome in liver tissue and circulation by competitive reverse transcription-polymerase chain reaction. Dig Dis Sci 39:225
58. Nayersina R, Fowler P, Giulhot S, Missale G, Cerny A, Schlicht H-J. Vitiello A, Chesnut R, Person J, Redecker A, Chisari F (1993) HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 150:4659
59. Nelson DR, Marousis CG, Davis G, Rice CM, Wong J, Houghton M, Lau JYN (1997) The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 158:1473
60. Nowak M, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Koeppe B, Sigmund K, Bangham CRM, McMichael AJ (1995) Antigneic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606
61. Ogata N, Alter HJ, Miller RH, Purcell RH (1991) Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 88:3392
62. Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengede E, Kloetzel P-M, Neefjes J, Koszinowski U, Melief C (1996) A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115
63. Pantaleo G, Demarest JF, Schacker T, Vaccarezza M, Cohen OJ, Daucher M, Graziosi C, Schnittman SS, Quinn TC, Shaw GM, Perrin L, Tambussi G, Lazzarin A, Sekaly RP, Soudeyns H, Corey L, Fauci AS (1997) The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma virema. Proc Natl Acad Sci USA 94:254
64. Penna A, Chisari FV, Bertoletti A, Missale G, Fowler P, Giuberti T, Fiaccadori F, Ferrari C (1991) Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucle-ocapsid antigen. J Exp Med 174:1565
65. Phillips RE, Rowland JS, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR, McMichael AJ (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453
66. Ralston R, Thudium K, Berger K, Kuo C, Gervase B, Hall J, Selby M, Kuo G, Houghton M, Choo QL (1993) Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol 67:6753
67. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, Chisari FV (1996) Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 70:7092
68. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV (1996) Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98:1432
69. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A (1993) Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929
70. Sadovnikova E, Zhu X, Collins SM, Zhou J, Vousden K, Crawford L, Beverley P, Stauss HJ (1994) Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein. Int Immunol 6:289
71. Schoeman MN, Liddle C, Bilous M, Grierson J, Craig PI, Batey RG, Farrell GC (1990) Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression. Aust N J Med 20:56
72. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994) Neutralizing antibodies against hepatitis C virus and the emergence of neutraliztion escape mutant viruses. J Virol 68:1494
73. Sutton J, Rowland-Jones S, Rosenberg W, et al (1993) A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol 23:447
74. Takahashi H, Merli S, Putney SD, Houghten R, Moss B, Germain RN, Berzofsky JA (1989) A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science 246:118
75. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ (1986) The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959
76. Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M, Yamamura K-I (1994) Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc Natl Acad Sci USA 91:614
77. Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, Eisen HN (1994) Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med 180:1283
78. Van der Burg SH, Klein MR, Van de Velde CJ, Kast WM, Miedema F, Melief CJ (1995) Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9:121
79. Walker BD, Flexner C, Birch LK, Fisher L, Paradis TJ, Aldovini A, Young R, Moss B, Schooley RT (1989) Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 86:9514
80. Walter E, Greenberg P, Gilbert M, Finch R, Watanabe K, Thomas E, Riddell S (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038
81. Weiner AJ, Geysen HM, Christopherson C, et al (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 89:3468
82. Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, Houghton M, Walker CM (1995) Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 92:2755
83. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT, Koup RA (1996) Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537
84. Wong DK, Dudley D, Afdhal N, Rice C, Houghton M, Walker BD, Koziel MJ (1996) Liver-derived cytotoxic T lymphocytes in non-resolving hepatitis C infection (Abstract A1361). Dig Dis Week, San Francisco CA
85. Wong JT, Colvin RB (1987) Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J Immunol 139:1369
86. Yang OO, Kalams SA, Rosenzweig M, Trocha A, Koziel M, Walker BD, Johnson RP (1996) Efficient lysis of HIV-1 infected cells by cytotoxic T lymphocytes. J Virol 70:5799
87. + cells: evidence for HLA class I restricted triggering of cytolytic and non-cytolytic mechanisms. J Virol 71:3120
88. Yap KL, Ada GL (1978) Cytotoxic T cells in the lungs of mice infected with influenza A virus. Scand J Immunol 7:73
89. Yap KL, Braciale TJ, Ada GL (1979) Role of T-cell function in recovery from murine influenza infection. Cell Immunol 43:341
90. Zinkernagel RM, Althage A (1977) Antiviral protection by virus-immune cytotoxic T cells. Infected target cells are lysed before infectious virus progeny is assembled. J Exp Med 145:644